The Food and Drug Administration has approved three GLP-1s specifically for obesity, including Wegovy, Zepbound and Saxenda.

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound and other anti-obesity drugs was third-highest in the ...

The end of Novo Nordisk’s supply problems could bring new headaches for the rest of the pharmaceutical industry, which now ...

It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...

Patients using weight loss drugs in the UK have overwhelmingly opted for Mounjaro over Wegovy in the last six months, ...

The proposed buyout of contract drug manufacturer Catalent won’t raise competition concerns, the European Commission said.

Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy ...

Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...

Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

Wegovy, the weight loss medication you can only get with a prescription from a licensed healthcare professional, may intrigue you. Here’s who is eligible and what to expect at your initial ...

A prescription for Wegovy in the UK is roughly the same price as an expensive gym's membership fees - from around £160 a month. Famous users in the public eye such as Robbie Williams ...